Quanterix (NASDAQ:QTRX) Stock Rating Upgraded by The Goldman Sachs Group

Quanterix (NASDAQ:QTRX – Get Rating) was upgraded by The Goldman Sachs Group from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, The Fly reports. The brokerage currently has a $27.00 price objective on the stock, up from their previous price objective of $13.00. The Goldman Sachs Group’s price […]

Related Keywords

,Nasdaq ,Goldman Sachs Group ,Quanterix Corp ,Platinum Investment Management Ltd ,Custom Assay Development ,Vanguard Group Inc ,Quanterix Company Profile ,Blackrock Inc ,Frontier Capital Management Co ,Simoa Accelerator Laboratory ,Granahan Investment Management ,Get Rating ,Capital Management ,Investment Management ,Platinum Investment Management ,Simoa Assay Kits ,Analysis System ,Custom Assay ,Quanterix Daily ,Quanterix ,Nasdaq Qtrx ,Qtrx ,Medical ,Upgrade ,The Goldman Sachs Group Inc ,